{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:49:11Z","timestamp":1786708151879,"version":"build-2736575974"},"reference-count":13,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ajogmf.2023.101151","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T17:33:21Z","timestamp":1694108001000},"page":"101151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Use of integrase inhibitors vs protease inhibitors is associated with improved HIV viral suppression"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5083-4893","authenticated-orcid":false,"given":"Whitney N.","family":"Kleinmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Pruszynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily H.","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2023.101151_bib0001","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/0033354918800466","article-title":"Reconsidering the number of women with HIV infection who give birth annually in the United States","volume":"133","author":"Nesheim","year":"2018","journal-title":"Public Health Rep"},{"key":"10.1016\/j.ajogmf.2023.101151_bib0002","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1542\/peds.2012-0194","article-title":"A framework for elimination of perinatal transmission of HIV in the United States","volume":"130","author":"Nesheim","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajogmf.2023.101151_bib0003","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2023.101151_bib0004","unstructured":"Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. 2011;1-207. Available at: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/PerinatalGL.pdf. Accessed December 21, 2022."},{"key":"10.1016\/j.ajogmf.2023.101151_bib0005","unstructured":"Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1- infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. National Institutes of Health; 2015. Available at: https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/archive\/PerinatalGuideline_8-6-15.pdf. Accessed December 21, 2022."},{"key":"10.1016\/j.ajogmf.2023.101151_bib0006","series-title":"Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States","year":"2023"},{"key":"10.1016\/j.ajogmf.2023.101151_bib0007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.2022.22246","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the international antiviral society-USA panel","volume":"329","author":"Gandhi","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2023.101151_bib0008","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/QAI.0b013e31829f05ac","article-title":"Viral load monitoring as a tool to reinforce adherence: a systematic review","volume":"64","author":"Bonner","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajogmf.2023.101151_bib0009","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa2200600","article-title":"Dolutegravir in pregnancy as compared with current HIV regimens in the United States","volume":"387","author":"Patel","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2023.101151_bib0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ajog.2015.12.052","article-title":"Integrase inhibitors in late pregnancy and rapid HIV viral load reduction","volume":"214","author":"Rahangdale","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101151_bib0011","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1080\/14767058.2019.1691987","article-title":"Comparison of two combined antiretroviral treatment regimens in the management of HIV in pregnancy: an observational study","volume":"34","author":"Tate","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2023.101151_bib0012","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJMoa1905230","article-title":"Neural-tube defects and antiretroviral treatment regimens in Botswana","volume":"381","author":"Zash","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2023.101151_bib0013","unstructured":"Zash R, Holmes LB, Diseko M, et al. Update on neural tube defects with antiretoviral exposure in the Tsepamo study. Republic of Botswana; 2021."}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933323002938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933323002938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:52:28Z","timestamp":1762905148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933323002938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2589933323002938"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2023.101151","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of integrase inhibitors vs protease inhibitors is associated with improved HIV viral suppression","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2023.101151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101151"}}